Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer

Authors

Moritz Hommerding

Published

August 22, 2024

Abstract

This study seeks to contribute real-world data on the prevalence of BRCA1/2 and HRR gene mutations in prostate cancer.

Supporters

Support the authors with ResearchCoin

Journal

World Journal of Urology

Topics

DOI

10.1007/s00345-024-05188-7

License

CC-BY

Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer

Authors

Moritz Hommerding

Published

August 22, 2024

Abstract

This study seeks to contribute real-world data on the prevalence of BRCA1/2 and HRR gene mutations in prostate cancer.

Supporters

Support the authors with ResearchCoin

Journal

World Journal of Urology

Topics

DOI

10.1007/s00345-024-05188-7

License

CC-BY

Paper

Paper

Paper

Paper

Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer

Abstract

Supporters

Journal

Topics

DOI

License

Real-world data on the prevalence of BRCA1/2 and HRR gene mutations in patients with primary and metastatic castration resistant prostate cancer

Abstract

Supporters

Journal

Topics

DOI

License

Supporters

Journal

Topics

DOI

License